Insider Transactions Reported by 13 Insiders of AYTU BIOPHARMA, INC

Symbol
AYTU on Nasdaq
Location
Denver, CO

Insiders trading volume in the past year

AYTU BIOPHARMA, INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nantahala Capital Management, LLC 10%+ Owner $7,222,343 +$5,999,600 +491% 06 Jun 2025
ARMISTICE CAPITAL, LLC Director $5,017,808 20 Mar 2021
Joshua R. Disbrow Chief Executive Officer, Director $486,927 +$99,999 +26% 03 Oct 2025
Gary Cantrell Director $306,682 21 Dec 2022
Jarrett Disbrow Chief Business Officer $144,684 +$24,999 +21% 03 Oct 2025
Ryan J. Selhorn Chief Financial Officer $116,896 03 Oct 2025
GREG PYSZCZYMUKA Chief Commercial Officer $84,839 03 Oct 2025
VIVIAN H. LIU Director $46,588 03 Oct 2025
ABHINAV JAIN Director $45,825 03 Oct 2025
CARL DOCKERY Director $36,215 03 Oct 2025
John Donofrio Jr. Director $32,340 03 Oct 2025
Mark K. Oki Chief Financial Officer 11 Aug 2023
CHRISTOPHER BROOKE Chief Operating Officer 11 Aug 2023

Recent Insider Transactions by Companies or Individuals for AYTU BIOPHARMA, INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.